# Phase 1 Study of the Litx™ BPH System in Patients With Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)

> **NCT00709488** · PHASE1 · COMPLETED · sponsor: **Light Sciences Oncology** · enrollment: 12 (actual)

## Conditions studied

- Benign Prostatic Hyperplasia
- Lower Urinary Tract Symptoms

## Interventions

- **DRUG:** Talaporfin sodium
- **PROCEDURE:** Placement of device in prostate urethra
- **DEVICE:** Transurethral illumination with light emitting diodes (Litx™ BPH Device)

## Key facts

- **NCT ID:** NCT00709488
- **Lead sponsor:** Light Sciences Oncology
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2011-04
- **Final completion:** 2011-04
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2012-11-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00709488

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00709488, "Phase 1 Study of the Litx™ BPH System in Patients With Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00709488. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*